Ovarian Cyst Removal in India
Get Ovarian Cyst Removal at internationally accredited (JCI/NABH) Indian hospitals at a fraction of Western costs, with end-to-end international patient support — visa, travel, stay, and follow-up care.
Ovarian Cyst Removal in UAE
Ovarian Cyst Removal at leading UAE hospitals in Dubai and Abu Dhabi — world-class care closer to home, visa-free entry for many nationalities, international specialists, and modern facilities.
Overview
Ovarian cyst removal surgery — encompassing laparoscopic cystectomy, oophorectomy, and robotic-assisted excision — is performed to eliminate benign, borderline, or malignant ovarian cysts that cause pelvic pain, hormonal disruption, or fertility compromise, with clinical success rates exceeding 95% for laparoscopic approaches in experienced hands. GAF Healthcare connects international patients with JCI- and NABH-accredited hospitals in India and JCI- and DHA-licensed centres in Dubai and Abu Dhabi, where minimally invasive gynaecological surgery is performed by fellowship-trained laparoscopic and robotic surgeons. Patients travelling through GAF Healthcare benefit from cost savings of up to 60% compared with Western or Gulf private rates, concierge visa facilitation, and a dedicated medical coordinator from inquiry through discharge.
Hospital Stay: 1–3 days (laparoscopic/robotic); 3–5 days (open laparotomy) • Total Stay in Country (Fit-to-Fly): 1–2 weeks (laparoscopic/robotic, short-haul); 2–3 weeks (open approach or complex cases, long-haul international flight) • Success Rate: 95–98% (laparoscopic cystectomy, benign pathology); 88–92% (borderline/malignant with staging)
What Is It?
Ovarian cysts are fluid-filled or semi-solid sacs that develop on or within the ovary, arising from a spectrum of pathological processes including functional follicular or corpus luteum activity, endometriosis (endometriomas), benign epithelial neoplasms (serous or mucinous cystadenomas), dermoid cysts (mature cystic teratomas), polycystic ovarian morphology, or, less commonly, borderline and frankly malignant tumours. Physiologically, large or complex cysts distort the ovarian stroma, compress adjacent pelvic viscera, and can trigger adnexal torsion — a surgical emergency in which the ovarian blood supply is compromised, risking permanent gonadal loss. Hormonal sequelae, including anovulation and secondary dysmenorrhoea, are common in endometrioma-associated and polycystic disease, with measurable suppression of anti-Müllerian hormone (AMH) reflecting diminished ovarian reserve in advanced cases.
The contemporary standard of care stratifies management using validated risk tools. The Risk of Malignancy Index (RMI) and IOTA (International Ovarian Tumour Analysis) Simple Rules — incorporating ultrasound morphology, serum CA-125, CEA, HE4, and menopausal status — guide the triage of patients toward expectant management, laparoscopic excision, or formal oncological staging. Ultrasound (transvaginal and transabdominal), MRI pelvis with contrast, and occasionally PET-CT are employed to characterise cyst complexity, define septal thickness, detect solid components, and exclude metastatic disease before surgical planning is finalised.
Surgical removal remains the definitive intervention when cysts exceed 5–6 cm, demonstrate complex ultrasonographic features (Bosniak III–IV equivalent morphology on gynaecological assessment), cause acute or chronic symptoms, are associated with infertility, or carry malignancy suspicion. Ovary-conserving cystectomy is prioritised in premenopausal women to preserve hormonal function and fertility; oophorectomy (unilateral or bilateral) is reserved for postmenopausal patients, recurrent pathology, or confirmed malignancy where comprehensive surgical staging — including peritoneal washing cytology, omentectomy, pelvic and para-aortic lymph node sampling — becomes mandatory.
Candidates
• Women of any age with persistent ovarian cysts ≥5–6 cm confirmed on two serial ultrasounds 6–12 weeks apart
• Patients with complex cysts exhibiting solid components, thick septations (>3 mm), internal vascularity on Doppler, or elevated tumour markers (CA-125 >35 U/mL, HE4 above age-adjusted threshold)
• Premenopausal women with endometriomas ≥4 cm associated with pelvic pain, dyspareunia, or subfertility undergoing IVF workup
• Acute adnexal torsion (emergency indication regardless of cyst size)
• Dermoid cysts (mature cystic teratomas) of any symptomatic size due to torsion risk and chemical peritonitis potential
• Postmenopausal women with any new-onset ovarian cyst regardless of size, given elevated malignancy risk
• Women with BRCA1/BRCA2 mutations opting for risk-reducing bilateral salpingo-oophorectomy (RRSO)
• Patients requiring fertility preservation counselling prior to oncological oophorectomy (oocyte or embryo cryopreservation discussed with reproductive endocrinologist pre-operatively)
Required pre-operative diagnostics:
• Transvaginal ultrasound (TVS) with Doppler — primary imaging modality
• MRI pelvis with gadolinium contrast — mandatory for complex or indeterminate cysts
• PET-CT — selectively in high RMI scores or when metastatic disease must be excluded
• Serum tumour markers: CA-125, HE4 (ROMA score calculation), CEA, CA 19-9, AFP, LDH, inhibin B (germ cell tumours)
• Complete blood count, coagulation profile (PT/INR, aPTT), renal and hepatic function panel
• Hormonal panel: FSH, LH, AMH, oestradiol (fertility-relevant cases)
• Pre-anaesthetic evaluation including ECG and echocardiogram (ECHO) where cardiac history exists
• Cervical cytology (Pap smear) and endometrial biopsy if concurrent uterine pathology is suspected
Contraindications and cautions:
• Active intra-abdominal or pelvic infection (absolute contraindication to elective laparoscopy until resolved)
• Uncorrected coagulopathy or therapeutic anticoagulation not bridged pre-operatively
• Severe cardiopulmonary compromise precluding Trendelenburg positioning and CO₂ pneumoperitoneum (relative — anaesthetic optimisation required)
• Multiple prior laparotomies with expected dense adhesions (transition to open approach planned)
• Confirmed advanced ovarian malignancy where neoadjuvant chemotherapy (NACT) with interval debulking is oncologically preferred over upfront surgery
Procedure
Laparoscopic Ovarian Cystectomy (Standard Minimally Invasive Approach) This is the gold-standard treatment for benign and presumed-benign ovarian cysts in premenopausal women. Three to four 5–12 mm ports are placed under CO₂ pneumoperitoneum (intra-abdominal pressure 12–15 mmHg). The cyst is dissected from the ovarian cortex using the stripping technique (Donnez method) or the three-puncture hydrodissection technique to minimise damage to primordial follicles and preserve AMH-producing cortical tissue. Endobags (EndoCatch pouches) are used for cyst extraction to prevent intraperitoneal spillage — a critical step for dermoids and borderline tumours. Bipolar energy (LigaSure, PK forceps) or ultrasonic dissection (Harmonic ACE) achieves haemostasis with minimal thermal spread. Post-cystectomy ovarian reconstruction using 2-0 polyglactin (Vicryl) sutures or tissue glue (TissuGlu) optimises cortical closure and reduces adhesion formation.
Robotic-Assisted Laparoscopic Surgery (da Vinci Xi/Si Platform) Robotic cystectomy offers wristed instrument articulation (7 degrees of freedom), tremor filtration, and 3D-HD magnification, conferring advantages in complex anatomical situations — deep ovarian endometriomas, cysts with dense posterior adhesions, or when concurrent procedures (myomectomy, salpingostomy) are planned. The da Vinci Xi system, available at tertiary centres in India (Apollo, Fortis, Manipal) and the UAE (Cleveland Clinic Abu Dhabi, Mediclinic City Hospital Dubai), is particularly advantageous for surgeons managing cysts adjacent to the ureter or ovarian hilum where precision dissection is paramount. Docking time adds 10–15 minutes but operative field control is superior for complex or recurrent endometriomas.
Laparoscopic Oophorectomy and Salpingo-Oophorectomy Unilateral or bilateral adnexal removal is performed laparoscopically when cyst-ovary separation is impossible (extensive endometriosis, large dermoid occupying >80% of ovarian volume), in postmenopausal patients where ovarian conservation holds no hormonal benefit, or as risk-reducing surgery (RRSO) for BRCA carriers. The infundibulopelvic ligament is secured with advanced bipolar energy or stapling devices (Echelon Flex endoscopic stapler). Bilateral oophorectomy in premenopausal women mandates pre-operative and post-operative discussion of surgical menopause management, including hormone replacement therapy (HRT) initiation.
Open Laparotomy (Exploratory Laparotomy with Cystectomy or Staging) Indicated when malignancy is confirmed or strongly suspected (high RMI, solid vascular masses, ascites, peritoneal deposits on imaging). A midline or Pfannenstiel incision provides access for comprehensive staging: peritoneal cytology, omentectomy, bilateral pelvic and para-aortic lymph node dissection, appendectomy (mucinous tumours), and diaphragmatic assessment. Cytoreductive debulking surgery follows FIGO staging criteria. Intraoperative frozen section analysis of the cyst wall by an onco-pathologist guides the extent of resection in real-time. Post-operatively, adjuvant platinum-based chemotherapy (carboplatin + paclitaxel) is initiated for FIGO Stage IC and above epithelial ovarian cancers.
Image-Guided Aspiration (Ultrasound-Guided Cyst Aspiration) A non-surgical option reserved for simple, unilocular, thin-walled cysts in elderly or high-operative-risk patients, or as a temporising measure. Transvaginal ultrasound-guided aspiration and alcohol sclerotherapy (ethanol 95%, 10-minute dwell time) achieves 60–80% resolution for simple cysts but carries a significant recurrence rate compared with surgical excision. It is not appropriate for complex, septated, or solid-component cysts due to inadequate sampling for histopathology and malignancy risk.
Fertility-Sparing Approaches and Adjuncts In women with endometriomas undergoing IVF, GnRH agonist (leuprolide acetate, 3.75 mg monthly depot) or GnRH antagonist pre-treatment suppresses residual endometrial tissue and reduces post-operative recurrence. Dienogest 2 mg daily post-operatively for 6–24 months is the evidence-based medical adjunct for endometrioma recurrence prevention (ESHRE Endometriosis Guideline 2022). Ovarian tissue cryopreservation may be considered in specific oncological contexts under reproductive oncology protocols.
Cost of Ovarian Cyst Removal: India vs. UAE
The cost of ovarian cyst removal surgery varies substantially depending on the surgical approach (laparoscopic vs. robotic vs. open staging), cyst complexity, need for intraoperative frozen section or oncological staging, and the destination hospital's tier and accreditation status. India offers world-class gynaecological laparoscopic and robotic surgery at 40–60% lower cost than the UAE, while the UAE provides premium infrastructure, multilingual care, and proximity for patients from the Gulf region, Africa, and Eastern Europe. The estimates below reflect all-inclusive surgical packages at JCI-accredited facilities arranged through GAF Healthcare, covering surgeon's fee, anaesthesiologist fee, operating theatre charges, hospital room (standard to semi-private), standard post-operative medications, and routine pathology. Robotic surgery, oncological staging, extended ICU stay, or fertility preservation procedures will attract additional costs.
| Destination | Estimated Cost (USD) | Key Advantage |
|---|---|---|
| India | $1,500 – $5,000 | ~57% less than the UAE |
| UAE (Dubai/Abu Dhabi) | $4,000 – $11,000 | Premium care, JCI/DHA accredited |
Estimates typically include surgery, hospital stay, and standard medications. Contact us for a personalised quote.
Recovery & Aftercare
Pre-Operative Phase (Weeks 1–2 before surgery — completed partially remotely with GAF Healthcare coordination)
• Step 1 — Remote Consultation and Case Review: Patient submits ultrasound reports, MRI images (DICOM format), tumour marker results, and surgical history to GAF Healthcare's medical team. A specialist gynaecological surgeon reviews the case and provides a written opinion, operative plan, and cost estimate within 48–72 hours.
• Step 2 — Diagnostic Workup Confirmation: On arrival or at a pre-arranged partner laboratory, the following are confirmed or repeated: TVS, serum CA-125/HE4/ROMA, full blood panel, coagulation screen, cross-match blood type, pre-anaesthetic ECHO (if indicated), and baseline AMH for fertility-relevant patients.
• Step 3 — Anaesthetic and Surgical Consent: The treating anaesthesiologist performs a formal pre-anaesthetic assessment. The surgeon conducts an in-person consultation, confirms the operative approach (laparoscopic vs. robotic vs. open), and obtains informed consent including discussion of intraoperative frozen section, potential oophorectomy, and spillage risks.
• Step 4 — Pre-operative Optimisation: Bowel preparation (low-fibre diet 2 days prior; mechanical bowel prep selectively for complex cases), thromboembolic prophylaxis planning (LMWH — enoxaparin 40 mg subcutaneous — commenced night before or post-operatively), antibiotic prophylaxis (cefazolin 2 g IV 30–60 minutes pre-incision), and anaemia correction if haemoglobin <10 g/dL (IV iron infusion or erythropoietin stimulating agent).
Surgical Day (Day 0)
• Step 5 — Operating Theatre: Patient is placed in the dorsal lithotomy position with steep Trendelenburg (15–20°). After induction of general anaesthesia with endotracheal intubation, a Foley catheter and uterine manipulator (Hohl or RUMI II) are placed. Veress needle or Hasson open-entry technique establishes pneumoperitoneum. Ports are sited, pelvis inspected, and the cyst is excised per the planned approach. Intraoperative frozen section of the cyst wall is sent if any suspicious features are encountered. Total operative time: 45–90 minutes (laparoscopic cystectomy); 90–150 minutes (robotic or staged bilateral procedures).
• Step 6 — Recovery Room: Patient is observed for 2–3 hours in the post-anaesthesia care unit (PACU), monitoring for haemodynamic stability, haemoperitoneum (tachycardia, falling haematocrit), and shoulder-tip pain (diaphragmatic CO₂ irritation, managed with NSAIDs and low Trendelenburg positioning).
Hospital Stay (Days 1–3)
• Step 7 — Ward Recovery: Oral fluids commenced within 4–6 hours post-operatively. Multimodal analgesia: paracetamol 1 g QID + ketorolac 30 mg IV + tramadol PRN. DVT prophylaxis with LMWH and compression stockings. Discharge criteria: tolerating oral intake, pain VAS <4/10, mobile, no fever, satisfactory post-operative haemoglobin.
• Step 8 — Histopathology: Formal paraffin-section histopathology results are available in 5–7 business days. GAF Healthcare coordinates transmission of the report to the patient's home-country gynaecologist.
Post-Operative Recovery and Milestones
• Day 1–3: Discharge from hospital (laparoscopic). Light walking encouraged.
• Day 7: Wound review; staples or non-absorbable sutures removed if applicable. Port-site wounds inspected for infection.
• Week 1–2: Return-to-flight window for short-haul flights (laparoscopic, uncomplicated). No heavy lifting >5 kg. Pelvic rest (no intercourse, tampons, or douching).
• Week 2–3: Return-to-flight window for long-haul international flights (>6 hours). All patients fitted to fly must be assessed by the surgeon — deep vein thrombosis risk is elevated post-gynaecological surgery.
• Week 4–6: Gradual return to non-strenuous work. Light exercise (walking, swimming after wound closure) permitted at 4 weeks.
• Week 6–8: Full physical recovery milestone. Resumption of sexual activity and strenuous exercise permissible after surgical review. Fertility treatment (IVF cycle) may commence 8–12 weeks post-operatively.
• Week 12: Follow-up pelvic ultrasound and repeat tumour markers to confirm resolution and exclude early recurrence.
• Ongoing: For endometrioma-related surgery, medical suppression with dienogest or combined OCP commenced post-operatively to reduce 30–40% 5-year recurrence rate.
Risks & Considerations
Ovarian cyst removal surgery is well-tolerated in the majority of patients, but as with all intraperitoneal surgery, specific risks must be transparently discussed during pre-operative consent. Intraoperative cyst rupture and spillage occurs in 15–40% of laparoscopic cystectomies — while inconsequential for benign simple cysts, spillage of a borderline tumour's epithelial contents into the peritoneal cavity upstages the disease (FIGO IC1) and may influence the need for adjuvant chemotherapy; meticulous endobag use mitigates but does not eliminate this risk. Post-operative haemorrhage from the ovarian pedicle or cortical bed requires re-laparoscopy or conversion to laparotomy in approximately 1–2% of cases. Ovarian reserve reduction is an inherent consequence of cystectomy when the stripping technique inadvertently removes primordial follicles alongside the cyst wall — particularly significant for endometriomas, where studies document mean AMH decline of 30–40% post-operatively; this must be explicitly discussed with women planning future pregnancy. Infection — port-site cellulitis, pelvic abscess — occurs in <2% of patients and is managed with broad-spectrum antibiotics (piperacillin-tazobactam). Injury to adjacent structures — ureter, bowel, bladder, iliac vessels — is rare (<0.5%) but constitutes the most serious intraoperative complication, requiring immediate repair and extended hospital stay. Venous thromboembolism (DVT and pulmonary embolism) risk is elevated in the post-operative period, particularly relevant for medical tourists undertaking long-haul return flights; LMWH prophylaxis for 7–10 days post-discharge is standard and GAF Healthcare ensures patients receive prescriptions and injection training before departure. Recurrence of endometriomas occurs in 30–40% of patients within 5 years without post-operative medical suppression. Premature ovarian insufficiency is a rare but recognised complication of bilateral oophorectomy in premenopausal women, necessitating HRT to mitigate cardiovascular and bone density consequences.
Top Hospitals for Ovarian Cyst Removal
The following JCI and NABH-accredited hospitals are among the most experienced in specialist care, with dedicated teams and high-volume programmes.
Manipal Hospitals Dwarka
New Delhi, India
Burjeel Hospital for Advanced Surgery Dubai
Dubai, UAE
Kings College Hospital Dubai
Dubai, UAE
Aster Hospital Dubai
Dubai, UAE
Top Doctors for Ovarian Cyst Removal
Internationally trained specialists in Gynecology. Review their profiles, compare experience, and connect directly through GAF Healthcare.
Dr. Tarang Preet Kaur
MBBS, MS, MRCOG, MCh, Fellowship in Urogynaecology, Fellowship in Cosmetic Gynaecology
Urogynaecologist
Max Super Speciality Hospital, Saket, New Delhi, India
11+ Yearsof experience
Dr. Tarang Preet Kaur is a Consultant in Urogynaecology with over 11 years of clinical experience, currently practicing at Max Super Speciality Hospital, Saket in New Delhi. She holds an MCh in Urogynaecology from Edge Hill University, United Kingdom (2024), the MRCOG from the Royal College of Obstetricians & Gynaecologists, and an MS in Obstetrics & Gynaecology from Maulana Azad Medical College, Delhi. Her dual qualification across India and the UK… Read more
Dr. Amrinder Kaur Bajaj
MBBS, MD — Obstetrics & Gynaecology (Gold Medalist), Senior Residency — Obstetrics & Gynaecology, FRSH — Fellow of the Royal Society of Health, FIAMS — Fellow of the Indian Association of Medical Specialists
Obstetrician & Gynaecologist
Fortis Hospital, Gurgaon, Gurgaon, India
42+ Yearsof experience
Dr. Amrinder Kaur Bajaj is one of Delhi-NCR's most experienced gynaecologists, with over four decades spent caring for women at every stage of life. She currently practises as a Consultant in Obstetrics & Gynaecology at Fortis Hospital, Gurgaon, where she brings together deep clinical knowledge and a quietly reassuring bedside manner that patients — and their families — find genuinely comforting. Her academic journey set a high bar early on. She completed… Read more
Dr. Anuradha Khurana
MBBS, DGO (Diploma in Obstetrics & Gynaecology), PG in High Risk Pregnancy and Infertility
Gynecologist & Obstetrics Specialist
Artemis Hospital, New Delhi, India
20+ Yearsof experience
Dr. Anuradha Khurana is a Senior Consultant in Obstetrics and Gynecology at Artemis Hospital, Delhi, with over two decades of hands-on experience in women's health. She is particularly well regarded for her work in high-risk pregnancy management, uterine conditions like fibroids and endometriosis, and complex gynecological surgeries. Patients and families consistently describe her as someone who takes the time to truly listen — and to explain things in a… Read more
Dr. Aswari Kesari Kapoor
MBBS, DGO (Diploma in Gynaecology & Obstetrics), CPS (College of Physicians and Surgeons), DNB (Diplomate of National Board) — Obstetrics & Gynaecology
Obstetrician & Gynecologist
Indraprastha Apollo Hospital, New Delhi, India
23+ Yearsof experience
Dr. Aswari Kesari Kapoor is a seasoned Obstetrician and Gynecologist with over 23 years of hands-on clinical experience. She practices at Indraprastha Apollo Hospital in New Delhi — one of India's most respected multi-specialty institutions. Over the course of her career, she has built a strong reputation for managing complex gynecological conditions alongside high-risk pregnancies, all with a calm and reassuring bedside manner that patients consistently… Read more
Dr. Bindhu K S
MBBS, DNB (Obstetrics & Gynecology), Fellowship in Minimal Access Surgery, FICOG (Fellowship of the Indian College of Obstetricians and Gynaecologists), Certificate in Gynecologic and Obstetric Sonography, Certificate in Appreciation of Well Being in Fetal Heart Disease
Obstetrician & Gynecologist
Apollo Hospitals, Navi Mumbai, Mumbai, India
23+ Yearsof experience
Dr. Bindhu K S is a seasoned Obstetrician and Gynecologist based in Mumbai, currently practicing at Apollo Hospitals, Navi Mumbai. With over two decades of clinical experience, she brings together expertise in both obstetrics and advanced minimally invasive gynecologic surgery. Whether a patient comes with a complex fibroid, troublesome endometriosis, or a high-risk pregnancy, Dr. Bindhu approaches each situation with careful thought and genuine care. Her… Read more
Frequently Asked Questions — Ovarian Cyst Removal
The all-inclusive cost of ovarian cyst removal surgery at JCI- or NABH-accredited hospitals in India arranged through GAF Healthcare ranges from approximately USD 1,500 to USD 5,000, covering the surgeon's fee, anaesthesiologist, operating theatre, 1–3 day hospital stay, standard post-operative medications, and routine histopathology. Laparoscopic cystectomy for a straightforward benign cyst sits at the lower end of this range, while robotic-assisted or complex cases with intraoperative frozen section and oncological staging approach the upper end. In the UAE (Dubai and Abu Dhabi), the equivalent procedures at JCI- and DHA-accredited hospitals range from approximately USD 4,000 to USD 11,000 — reflecting higher infrastructure, staffing, and regulatory compliance costs in the Gulf. India is therefore typically 40–60% less expensive than the UAE for the same surgical quality and accreditation standard. Neither estimate includes international flights, travel insurance, or hotel accommodation for attendants; GAF Healthcare provides itemised cost plans incorporating all anticipated expenses to allow patients to budget accurately before travel.
The minimum recommended in-country stay before international air travel depends on the surgical approach and individual recovery trajectory. For uncomplicated laparoscopic ovarian cystectomy — the most common procedure — the hospital stay is 1–3 days, and most patients are medically cleared for short-haul flights (under 4–5 hours) by day 7–10 post-operatively, contingent on surgeon review confirming wound healing and absence of complications. For long-haul international flights (6 hours or more), which carry significantly elevated risk of deep vein thrombosis and pulmonary embolism in the post-gynaecological surgery period, a minimum of 14–21 days in-country is strongly recommended. Patients undergoing open laparotomy with oncological staging should plan for a 3–4 week in-country stay before any long-haul flight. Before departure, all GAF Healthcare patients receive a written fitness-to-fly certificate from their operating surgeon, a prescription for low-molecular-weight heparin (e.g., enoxaparin 40 mg subcutaneous injection) for the flight duration if indicated, and specific instructions on in-flight hydration, compression stockings, and hourly ambulation to minimise thromboembolism risk.
Success rates for ovarian cyst removal surgery are high when defined as complete excision with symptom resolution and low recurrence at JCI-accredited centres. For laparoscopic cystectomy of benign ovarian cysts (dermoids, serous and mucinous cystadenomas, functional cysts), complete excision rates exceed 95–98%, with symptom resolution — pain, pressure, and dysmenorrhoea — reported in over 90% of patients at 6-month follow-up. Recurrence rates for benign non-endometriotic cysts after complete laparoscopic excision are low, approximately 5–15% at 5 years. For endometriomas specifically, recurrence rates are higher — 30–40% at 5 years without post-operative medical suppression — which is why GAF Healthcare's partner surgeons routinely prescribe post-operative dienogest (2 mg daily) or combined oral contraceptive pill to reduce this risk. In cases involving borderline ovarian tumours managed with fertility-sparing laparoscopic cystectomy and staging, 5-year recurrence-free survival rates are 80–90%. For frankly malignant ovarian tumours managed with laparotomy, comprehensive staging, and adjuvant platinum-based chemotherapy, overall 5-year survival varies by FIGO stage: approximately 90% for Stage I, 70–75% for Stage II, 30–45% for Stage III, and 15–20% for Stage IV — underscoring the critical importance of accurate pre-operative risk stratification and referral to high-volume oncological centres, which GAF Healthcare specifically facilitates.
Why Plan Your Treatment Through Gaf Healthcare?
GAF Healthcare provides end-to-end non-medical coordination to ensure international patients experience no logistical barriers to accessing ovarian cyst removal surgery in India or the UAE.
Visa Facilitation — India: GAF Healthcare's dedicated visa desk prepares and submits the e-Medical Visa application (valid for 60 days, triple entry) for the patient and up to two attendants (e-Medical Attendant Visa). Required documents — hospital invitation letter, diagnostic reports, passport copies — are compiled by our team. Processing typically takes 2–4 business days online through the Indian government portal.
Visa Facilitation — UAE: Patients from over 50 countries receive visa-on-arrival or 30-day free visa for the UAE. GCC residents and many Commonwealth nationals require no pre-arranged visa. For nationalities requiring a prior entry visa, GAF Healthcare liaises with the treating hospital's international patient services department to obtain a medical visa invitation letter, streamlining the process through UAE consulates.
Airport Transfers: Chauffeur-driven, climate-controlled vehicle transfers are arranged for all arrival and departure journeys and for inter-facility transfers (e.g., from hotel to hospital for pre-operative tests). For post-operative patients, vehicles are fitted with reclinable seating to ensure comfort during the recovery period.
Dedicated Medical Interpreter and Coordinator: A bilingual patient coordinator (speaking the patient's preferred language) is assigned as a single point of contact throughout the stay. This coordinator accompanies the patient to all clinical consultations, surgical consent discussions, and discharge briefings, ensuring no medical information is lost in translation.
Attendant Accommodation: GAF Healthcare maintains preferred-rate partnerships with hotels adjacent to partner hospitals in all destination cities (Delhi, Mumbai, Chennai, Hyderabad, Dubai, Abu Dhabi). Attendant accommodation ranging from budget serviced apartments to 4-star hotels is arranged as per patient preference, typically within a 5–10 minute drive of the treating hospital to facilitate daily visits during the hospital stay.
Post-Discharge Support: Before departure, GAF Healthcare ensures patients receive: complete discharge summary in English, histopathology report (digital DICOM and PDF format), post-operative medication prescription with generic equivalents available in the home country, emergency contact of the treating surgeon for telemedicine follow-up, and a fitness-to-fly certificate issued by the operating surgeon.